Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation - PubMed
Review
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
Steven H Itzkowitz et al. Am J Physiol Gastrointest Liver Physiol. 2004 Jul.
Free article
Abstract
Patients with ulcerative colitis and Crohn's disease are at increased risk for developing colorectal cancer. To date, no known genetic basis has been identified to explain colorectal cancer predisposition in these inflammatory bowel diseases. Instead, it is assumed that chronic inflammation is what causes cancer. This is supported by the fact that colon cancer risk increases with longer duration of colitis, greater anatomic extent of colitis, the concomitant presence of other inflammatory manifestations such as primary sclerosing cholangitis, and the fact that certain drugs used to treat inflammation, such as 5-aminosalicylates and steroids, may prevent the development of colorectal cancer. The major carcinogenic pathways that lead to sporadic colorectal cancer, namely chromosomal instability, microsatellite instability, and hypermethylation, also occur in colitis-associated colorectal cancers. Unlike normal colonic mucosa, however, inflamed colonic mucosa demonstrates abnormalities in these molecular pathways even before any histological evidence of dysplasia or cancer. Whereas the reasons for this are unknown, oxidative stress likely plays a role. Reactive oxygen and nitrogen species produced by inflammatory cells can interact with key genes involved in carcinogenic pathways such as p53, DNA mismatch repair genes, and even DNA base excision-repair genes. Other factors such as NF-kappaB and cyclooxygenases may also contribute. Administering agents that cause colitis in healthy rodents or genetically engineered cancer-prone mice accelerates the development of colorectal cancer. Mice genetically prone to inflammatory bowel disease also develop colorectal cancer especially in the presence of bacterial colonization. These observations offer compelling support for the role of inflammation in colon carcinogenesis.
Similar articles
-
Intestinal inflammation and cancer.
Ullman TA, Itzkowitz SH. Ullman TA, et al. Gastroenterology. 2011 May;140(6):1807-16. doi: 10.1053/j.gastro.2011.01.057. Gastroenterology. 2011. PMID: 21530747 Review.
-
Chronic inflammatory bowel disease and cancer.
Pohl C, Hombach A, Kruis W. Pohl C, et al. Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Hepatogastroenterology. 2000. PMID: 10690586 Review.
-
Triantafillidis JK, Nasioulas G, Kosmidis PA. Triantafillidis JK, et al. Anticancer Res. 2009 Jul;29(7):2727-37. Anticancer Res. 2009. PMID: 19596953 Review.
-
Cancer surveillance in inflammatory bowel disease: new molecular approaches.
Risques RA, Rabinovitch PS, Brentnall TA. Risques RA, et al. Curr Opin Gastroenterol. 2006 Jul;22(4):382-90. doi: 10.1097/01.mog.0000231812.95525.a7. Curr Opin Gastroenterol. 2006. PMID: 16760754 Review.
-
Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
Yang GY, Taboada S, Liao J. Yang GY, et al. Methods Mol Biol. 2009;511:193-233. doi: 10.1007/978-1-59745-447-6_9. Methods Mol Biol. 2009. PMID: 19347299
Cited by
-
Bajo-Grañeras R, Crespo-Sanjuan J, García-Centeno RM, Garrote-Adrados JA, Gutierrez G, García-Tejeiro M, Aguirre-Gervás B, Calvo-Nieves MD, Bustamante R, Ganfornina MD, Sanchez D. Bajo-Grañeras R, et al. Int J Colorectal Dis. 2013 Jun;28(6):751-66. doi: 10.1007/s00384-012-1616-2. Epub 2013 Jan 8. Int J Colorectal Dis. 2013. PMID: 23296401
-
Ueyama H, Fu KI, Ogura K, Murata S, Miyazaki A. Ueyama H, et al. Tech Coloproctol. 2014 May;18(5):503-7. doi: 10.1007/s10151-012-0863-0. Epub 2012 Jul 31. Tech Coloproctol. 2014. PMID: 22847839
-
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword.
Battram AM, Bachiller M, Martín-Antonio B. Battram AM, et al. Int J Mol Sci. 2020 Jun 18;21(12):4346. doi: 10.3390/ijms21124346. Int J Mol Sci. 2020. PMID: 32570952 Free PMC article. Review.
-
Inflammatory microenvironment in gastric premalignant lesions: implication and application.
Zhang S, Shen Y, Liu H, Zhu D, Fang J, Pan H, Liu W. Zhang S, et al. Front Immunol. 2023 Nov 15;14:1297101. doi: 10.3389/fimmu.2023.1297101. eCollection 2023. Front Immunol. 2023. PMID: 38035066 Free PMC article. Review.
-
Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.
Hodges K, Kennedy L, Meng F, Alpini G, Francis H. Hodges K, et al. Transl Gastrointest Cancer. 2012 Jul 1;1(2):138-150. Epub 2012 Feb 8. Transl Gastrointest Cancer. 2012. PMID: 22943044 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous